Psoriasis trials recruiting in Florida
All Psoriasis trials nationally
27
Recruiting in Florida
42
Cities with sites
Cities in Florida
Tampa 11Miami 10Hialeah 6Clearwater 5Plantation 5Orlando 4Boca Raton 3Miami Lakes 3Aventura 2Avon Park 2Coral Gables 2Hollywood 2
Recruiting trials in Florida
- A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
- A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
- A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
- Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
- Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
- Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Rheumatology Diet Study
- Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
- Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)